Acute Asthma Outcomes, Endotoxin and Oxidative Potential of Pollutant Particles
急性哮喘结果、内毒素和污染物颗粒的氧化电位
基本信息
- 批准号:8032030
- 负责人:
- 金额:$ 22.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAerosolsAffectAgeAirAir PollutantsAir PollutionAlveolar MacrophagesArchivesAsthmaBiological AssayCaliforniaCarbonChildCohort StudiesDataDiagnosisDithiothreitolElectronsEndotoxinsEpidemiologic MethodsExhalationExposure toForced expiratory volume functionFossil FuelsFutureGenerationsGoalsHealthInflammatoryInflammatory ResponseJointsKnowledgeMeasurementMeasuresMethodsModificationNitric OxideOutcomeOxidantsOxidation-ReductionOxidative StressOxygenParticulateParticulate MatterPathologyProductionPropertyPublic HealthPulmonary Function Test/Forced Expiratory Volume 1QuartzRattusReactive Oxygen SpeciesResearchRespiratory physiologySamplingSchoolsSiteSourceStudy SubjectSuperoxidesSuspension substanceSuspensionsTeflonTestingTimeToxicologyTracerUnited States Environmental Protection Agencyairway inflammationambient particleaqueousbiological adaptation to stressin vitro Assayin vitro Bioassayparticlepollutantrespiratorytrafficking
项目摘要
DESCRIPTION (provided by applicant): Experimental data suggest that endotoxin may interact with organic components of particulate matter (PM) air pollution to induce acute inflammatory response in the airways, but there are no repeated measures data to assess whether this occurs in children with asthma. We previously found associations between 10 repeated measures of daily personal air pollutant exposures and daily acute asthma outcomes in a panel cohort study of 58 school children with asthma ages 9-18 years who were followed in southern California. Using these existing data we will assess for the first time whether repeated personal exposure to endotoxin is an effect modifier of the relation between repeated exposure to air pollution and acute asthma outcomes in subjects with diagnosed asthma (Aim 1). Health outcomes will include airway inflammation (exhaled nitric oxide) and expiratory lung function. Air pollutants will include personal exposure to NO2 and to PM2.5 mass, elemental carbon, and organic carbon. Furthermore, experimental data also show that components of PM derived from the combustion of fossil fuels from traffic sources may have the potential to induce oxidative stress initiated by reactive oxygen species. However, the concentrations of these redox active components can be independent of total regulated PM mass (PM2.5). It is possible that associations previously observed between worsening asthma and PM2.5 were related to the ability of particle mixtures to induce oxidative stress and inflammatory responses, which are hallmarks of the underlying pathology of asthma. To address this issue, we will analyze the relation of asthma outcomes to the oxidant potential of ambient PM2.5 using in vitro bioassays of archived daily particle samples (Aim 2). We hypothesize that asthma outcomes will be related to the oxidant potential of the collected particle samples. We further hypothesize that the magnitude of associations of asthma outcomes with PM2.5 oxidant potential will be greater than that for PM2.5 mass. Finally, to tie the previous two aims together, we will evaluate effect modification of associations between asthma outcomes and the oxidant potential of ambient PM2.5 by exposure to endotoxin (Aim 3). The oxidant potential of ambient particle mixtures may interact more strongly with endotoxin than interactions of endotoxin with surrogate tracers of pro-oxidant organic particle components such as elemental carbon (Aim 1). In the proposed study, we will produce new findings from a panel cohort study to address gaps in knowledge and to demonstrate the potential usefulness of new methods of exposure assessment. This includes new data on the importance to asthma health from joint exposures to endotoxin and air pollution, and from exposure to PM that varies according to a key air pollutant property, its oxidant potential. Our long-term goal is to advance epidemiologic methods of researching air pollution and health by establishing greater coherence with experimental toxicology.
PUBLIC HEALTH RELEVANCE: The knowledge that will emerge from the proposed study of these subjects will be of benefit to public health by identifying whether the joint exposure to endotoxin and air pollution affects respiratory health outcomes among children with asthma. We will address major gaps in scientific knowledge by advancing understanding on the components of particulate air pollution that are responsible for associations of acute changes in asthma outcomes with total mass concentrations of regulated fine particulate matter. Our proposed use of repeated measurements of personal exposure to particles with different oxidant potential may influence the way future studies of air pollution and asthma are conducted.
描述(由申请人提供):实验数据表明,内毒素可能与颗粒物(PM)空气污染的有机成分相互作用,在气道中诱导急性炎症反应,但没有重复测量数据来评估这种情况是否发生在哮喘儿童中。我们之前在一项对58名9-18岁哮喘儿童的队列研究中发现了10项重复测量的每日个人空气污染物暴露与每日急性哮喘结局之间的相关性,这些儿童在南加州接受了随访。使用这些现有数据,我们将首次评估重复暴露于内毒素是否是诊断为哮喘的受试者重复暴露于空气污染和急性哮喘结局之间关系的影响因素(目的1)。健康结果将包括气道炎症(呼出的一氧化氮)和呼气肺功能。空气污染物将包括个人暴露于NO2和PM2.5质量,元素碳和有机碳。此外,实验数据还表明,来自交通来源的化石燃料燃烧的PM组分可能具有诱导由活性氧引发的氧化应激的潜力。然而,这些氧化还原活性组分的浓度可以独立于总的调节PM质量(PM2.5)。先前观察到的哮喘恶化与PM2.5之间的关联可能与颗粒混合物诱导氧化应激和炎症反应的能力有关,这是哮喘潜在病理学的标志。为了解决这个问题,我们将使用存档的每日颗粒物样本的体外生物测定来分析哮喘结果与环境PM2.5的氧化电位的关系(目的2)。我们假设哮喘的结果将与所收集的颗粒样品的氧化电位有关。我们进一步假设哮喘预后与PM2.5氧化潜能的关联程度将大于PM2.5质量。最后,为了将前两个目标联系起来,我们将评估暴露于内毒素对哮喘结果与环境PM2.5氧化潜力之间关联的影响(目标3)。环境颗粒混合物的氧化电位与内毒素的相互作用可能比内毒素与助氧化剂有机颗粒组分(如元素碳)的替代示踪剂的相互作用更强(目标1)。在拟议的研究中,我们将从一项小组队列研究中得出新的发现,以填补知识空白,并证明新的暴露评估方法的潜在有用性。这包括关于哮喘健康重要性的新数据,这些数据来自内毒素和空气污染的联合暴露,以及暴露于根据关键空气污染物特性(其氧化潜力)而变化的PM。我们的长期目标是通过与实验毒理学建立更大的一致性来推进研究空气污染和健康的流行病学方法。
公共卫生相关性:通过确定内毒素和空气污染的联合暴露是否会影响哮喘儿童的呼吸健康结果,从这些受试者的拟议研究中获得的知识将有利于公共卫生。我们将通过推进对颗粒空气污染成分的理解来解决科学知识中的重大空白,这些成分是哮喘结果急性变化与受管制细颗粒物总质量浓度相关的原因。我们建议使用重复测量的个人暴露于不同氧化电位的颗粒可能会影响未来的空气污染和哮喘的研究进行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RALPH J DELFINO其他文献
RALPH J DELFINO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RALPH J DELFINO', 18)}}的其他基金
Acute Asthma Outcomes, Endotoxin and Oxidative Potential of Pollutant Particles
急性哮喘结果、内毒素和污染物颗粒的氧化电位
- 批准号:
8207940 - 财政年份:2011
- 资助金额:
$ 22.95万 - 项目类别:
Pediatric asthma, photochemical oxidant air pollutants, and climate change vulner
小儿哮喘、光化学氧化剂空气污染物和气候变化脆弱性
- 批准号:
8305466 - 财政年份:2011
- 资助金额:
$ 22.95万 - 项目类别:
Pediatric asthma, photochemical oxidant air pollutants, and climate change vulner
小儿哮喘、光化学氧化剂空气污染物和气候变化脆弱性
- 批准号:
8152473 - 财政年份:2011
- 资助金额:
$ 22.95万 - 项目类别:
Air Pollution and Peripheral Blood Gene Expression in Subjects with Coronary Arte
空气污染与冠心病患者外周血基因表达
- 批准号:
7661193 - 财政年份:2009
- 资助金额:
$ 22.95万 - 项目类别:
Air Pollution and Peripheral Blood Gene Expression in Subjects with Coronary Arte
空气污染与冠心病患者外周血基因表达
- 批准号:
7846833 - 财政年份:2009
- 资助金额:
$ 22.95万 - 项目类别:
ULTRAFINE PARTICULATE MATTER & CARDIORESPIRATORY HEALTH
超细颗粒物
- 批准号:
7606628 - 财政年份:2006
- 资助金额:
$ 22.95万 - 项目类别:
Transcriptomic, Oxidative Stress, and Inflammatory Responses to Air Pollutants
对空气污染物的转录组、氧化应激和炎症反应
- 批准号:
8258226 - 财政年份:2003
- 资助金额:
$ 22.95万 - 项目类别:
Transcriptomic, Oxidative Stress, and Inflammatory Responses to Air Pollutants
对空气污染物的转录组、氧化应激和炎症反应
- 批准号:
8415850 - 财政年份:2003
- 资助金额:
$ 22.95万 - 项目类别:
Ultrafine Particulate Matter & Cardiorespiratory Health
超细颗粒物
- 批准号:
6806575 - 财政年份:2003
- 资助金额:
$ 22.95万 - 项目类别:
Ultrafine Particulate Matter & Cardiorespiratory Health
超细颗粒物
- 批准号:
6730183 - 财政年份:2003
- 资助金额:
$ 22.95万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.95万 - 项目类别:
Research Grant














{{item.name}}会员




